Case Studies

Foundational consumer segmentation to manage the formulations of a metabolic compound throughout its entire lifecycle.
Prescriber segmentation to inform the management of an oncology portfolio with new and in-line treatments.
Identify and prioritize drivers of physician and patient choices to guide the engineering design of a revolutionary device-based cardio-vascular treatment.
Segment the osteoporosis market in North America and Europe to support the introduction of a challenger therapy with a unique mode of action.
Integrated segmentation of alzheimer's caregivers and treaters to support new brand launch in US and global markets.
Treatment decision and patient flow mapping in mental health category.
Segmentation of nephrologists and chronic kidney disease patients in the US and global markets to inform the positioning for a new treatment.
Choice modeling to guide the defensive strategy for a market leader facing new competitor in oncology category.
Segmentation of primary care physicians and specialists to identify suitable targets for an extended release version of a branded therapy.
Led "wargaming" workshops for client seeking to anticipate impact of new entrant.
Behavioral targeting to assist client with re-prioritization of call lists for personal and non-personal promotion efforts.

Re-positioning of an in-line drug facing generic competition via integrated segmentation, message evaluation and visual aid testing with targeted health care professionals.
Identify the optimal message for a new dosing regimen of an in-line HIV drug.
Informed the design of a patient adherence program for a chronic condition via optimization of offers to drive trial and retention.
Quantitative testing of positionings and messages for women’s health Rx brands that had recently been acquired.
Determine the optimal elements of a refreshed visual aid to drive prescribing behavior.
Evaluate optimal brand names for a new OTC diagnostic device to ensure a fit with parent brand identity.
Determine optimal package design that would promote patient adherence for neuroscience treatment.

Parallel surveys of patients and physicians to identify disconnects in treatment of GI condition and to inform new condition name for regulatory discussions.
Measure return on DTC print advertising (presented at 2005 Worldwide Readership Symposium and 2006 ARF Audience Measurement Symposium)
Audit of multiple myeloma patient charts using KN’s proprietary MD-diary approach in order to determine accurate market share.
Determine physicians' treatment decision criteria for non small cell lung cancer via KN’s proprietary MD-diary approach.
Measure and track the brand equity for an in-line product undergoing a repositioning to evaluate progress against target segments.